TMCnet News

DSM concludes early redemption of €500 million bond
[June 16, 2021]

DSM concludes early redemption of €500 million bond


HEERLEN, Netherlands, June 16, 2021 /PRNewswire/ -- Royal DSM, a global science-based company in Nutrition, Health and Sustainable Living, today announces the final Make-whole Redemption Amount in relation to the early redemption of the €500 million 1.375% bond maturing 26 September 2022, issued under Prospectus dated 24 March 2015 of Koninklijke DSM N.V. (ISIN: XS1293087703) (the "Notes").

DSM Logo. (PRNewsFoto/DSM) (PRNewsFoto/DSM)

Further to its notice given on 19 May 2021, DSM hereby notifies holders of the Notes that the Make-whole Redemption Amount shall be €1,033.91 per €1,000 in principal amount of Notes inclusive of accrued and unpaid interest up to, but excluding, the Make-whole Redemption Date falling on 18 June 2021.

DSM – Bright Science. Brighter Living.™
Royal DSM is a global, purpose-led, science-based company active in Nutrition, Health and Sustainable Living. DSM's purpose is to create brighter lives for all. DSM addresses with its products and solutions some of the world's biggest challenges while simultaneously creating economic, environmental and societal value for all its stakeholders – customers, employees, shareholders, and society at large. DSM delivers innovative solutions for human nutrition, animal nutrition, personal care and aroma, medical devices, green products and applications, and new mobility and connectivity. DSM and its associated companies deliver annual net sales of about €10 billion with approximately 23,000 employees. The company was founded in 1902 and is listed on Euronext Amsterdam. More information can be found at www.dsm.com.

Or find us on:     
Facebook: http://www.facebook.com/DSMcompany
Twitter: http://www.twitter.com/DSM  
LinkedIn: http://www.linkedin.com/company/3108  
YouTube: http://www.youtube.com/user/dsmcompany

For more information:





DSM Media relations

Lieke de Jong

tel. +31 (0) 45 5782420

email media.contacts@dsm.com

DSM Investor Relations

Dave Huizing

tel. +31 (0) 45 5782864

email investor.relations@dsm.com 


Forward-looking statements
This press release may contain forward-looking statements with respect to DSM's future (financial) performance and position. Such statements are based on current expectations, estimates and projections of DSM and information currently available to the company. DSM cautions readers that such statements involve certain risks and uncertainties that are difficult to predict and therefore it should be understood that many factors can cause actual performance and position to differ materially from these statements. DSM has no obligation to update the statements contained in this press release, unless required by law. The English language version of the press release is leading.

Logo - https://mma.prnewswire.com/media/329419/dsm_logo.jpg  


[ Back To TMCnet.com's Homepage ]